Resources

Therapeutic areas
Diseases
Filter by type

Oncimmune’s CEO, Martin Gouldstone speaks to Vox Market about the company’s new strategy progress.

Read Article

Martine Gouldstone, CEO updates investors on Oncimmune’s new strategy

Read Article

Oncimmune to participate at the ASCO 2023 Meeting

Read Article

Siemens Healthineers and Oncimmune partner to improve malignancy risk assessment of indeterminate pulmonary nodules (IPNs)

Read Article